Researchers at the Korea Research Institute of Standards and Science (KRISS) have developed a revolutionary catalyst that dramatically boosts the efficiency and affordability of green hydrogen production, paving the way for a sustainable energy future.
Sherry A. Southerland and Jennifer Schellinger tell us what we need to know about Learning Through Collaborative Design-Professional Development (LCD PD) in this special science education focus.
A "human error" created a factory mixup for Johnson & Johnson in Baltimore, Maryland, damaging up to 15 million vaccine doses - but this does not impact doses that are ready for use.
Real-world use of the Moderna and Pfizer vaccines in the United States reveals that both are working at 90% efficacy - with data pointing to one dose being capable of 80% protection.
Tore K Kvien & Guro L Goll argue that biosimilars are an opportunity for improving access to treatment & reducing cost and provide comment on the NOR-SWITCH study.
Dr. James E Goldman and Dr. Osama Al-Dalahmah from the Department of Pathology and Cell Biology at Columbia University, provide an in-depth perspective on Huntington’s disease (HD) research.
ONS data from January shows that only 49% of Black British adults would take the COVID vaccine - the UK Government acknowledges that others are wary about the intention of "some institutions and authorities".
We spoke with Professor Colin Jones, project coordinator of CRESCENDO, about the project’s work in predicting global climate change over the coming century.
Richie Kohman, Synthetic Biology Platform Lead at Wyss Institute at Harvard, explains the use of next-generation sequencing to analyse biological tissues in a spatially resolved context.
According to new ONS data, 36% of UK people who are vaccine hesitant have strong side effect fears - while a further 12% fear needles, and 22% think vaccines could impact fertility.
In South Asia, global warming is set to create more deadly heat waves - with 60% of the region unable to take shelter and survive, due to working outdoors.
Lead Scientific Officer at Always Pure Organics Andrew Megahy, explains how the UK is now in a prime position for the future of CBD use, due to the Novel Foods Application.
